The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator–inducible T-cell costimulator ligand interaction
Open accessAbstract
Background: Atopic diseases, including asthma, exacerbate type 2 immune responses and involve a number of immune cell types, including regulatory T (Treg) cells and the emerging type 2 innate lymphoid cells (ILC2s). Although ILC2s are potent producers of type 2 cytokines, the regulation of ILC2 activation and function is not well understood. Objective: In the present study, for the first time, we evaluate how Treg cells interact with pulmonary ILC2s and control their function. Methods: ILC2s and Treg cells were evaluated by using in vitro suppression assays, cell‐contact assays, and gene expression panels. Also, human ILC2s and Treg cells were adoptively transferred into NOD SCID &ggr;C‐deficient mice, which were given isotype or anti–inducible T‐cell costimulator ligand (ICOSL) antibodies and then challenged with IL‐33 and assessed for airway hyperreactivity. Results: We show that induced Treg cells, but not natural Treg cells, effectively suppress the production of the ILC2‐driven proinflammatory cytokines IL‐5 and IL‐13 both in vitro and in vivo. Mechanistically, our data reveal the necessity of inducible T‐cell costimulator (ICOS)–ICOS ligand cell contact for Treg cell–mediated ILC2 suppression alongside the suppressive cytokines TGF‐&bgr; and IL‐10. Using a translational approach, we then demonstrate that human induced Treg cells suppress syngeneic human ILC2s through ICOSL to control airway inflammation in a humanized ILC2 mouse model. Conclusion: These findings suggest that peripheral expansion of induced Treg cells can serve as a promising therapeutic target against ILC2‐dependent asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asthma: From Bronchoconstriction to Airways Inflammation and Remodeling
BOUSQUET, J., JEFFERY, P. K., BUSSE, W. W., JOHNSON, M., & VIGNOLA, A. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9903102 · Cited by 1,702
Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549
Cited by
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Romano, M., Fanelli, G., Albany, C. J., Giganti, G., & Lombardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00043 · Cited by 512
Epithelial cell–derived cytokines: more than just signaling the alarm
Roan, F., Obata-Ninomiya, K., & Ziegler, S. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124606 · Cited by 484
Principles of regulatory T cell function
Dikiy, S., & Rudensky, A. Y. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.004 · Cited by 445
Type 2 immunity: Expanding our view
Lloyd, C. M., & Snelgrove, R. J. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat1604 · Cited by 334
The group 2 innate lymphoid cell ( ILC 2) regulatory network and its underlying mechanisms
Kabata, H., Moro, K., & Koyasu, S. (2018) · Immunological Reviews · doi:10.1111/imr.12706 · Cited by 293
Metadata
- Authors
- Rigas, D., Lewis, G., Aron, J. L., Wang, B., Banie, H., Sankaranarayanan, I., Galle-Treger, L., Maazi, H., Lo, R., Freeman, G. J., Sharpe, A. H., Soroosh, P., & Akbari, O.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 139
- Issue
- 5
- Pages
- 1468-1477.e2
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2554650621
- Cited by
- 186
- References
- 2
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.